Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Societal Cdmo Inc (SCTL)

Societal Cdmo Inc (SCTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,260
  • Shares Outstanding, K 105,691
  • Annual Sales, $ 94,640 K
  • Annual Income, $ -13,270 K
  • EBIT $ -3 M
  • EBITDA $ 6 M
  • 60-Month Beta 1.61
  • Price/Sales 1.22
  • Price/Cash Flow N/A
  • Price/Book 1.96
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.15
  • Most Recent Earnings $0.00 on 03/22/24
  • Next Earnings Date 05/08/24
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) +1,665,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0600 +3.77%
on 03/21/24
1.1000 unch
on 04/05/24
+0.0400 (+3.77%)
since 03/05/24
3-Month
0.3078 +257.37%
on 01/08/24
1.1000 unch
on 04/05/24
+0.7760 (+239.51%)
since 01/05/24
52-Week
0.2600 +323.08%
on 11/15/23
1.2800 -14.06%
on 06/09/23
+0.0300 (+2.80%)
since 04/05/23

Most Recent Stories

More News
Societal CDMO Reports Second Quarter 2022 Financial Results

Recorded Q2 Revenue of $23.2 Million, a 29% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Clinical Trial...

SCTL : 1.1000 (+0.92%)
Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates

Contracted Activities Touch Upon Broad Range of Societal’s Offerings from Clinical Trial Services to Formulation Development to cGMP Manufacturing Work...

SCTL : 1.1000 (+0.92%)
Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022

Webcast Scheduled for Wednesday, August 10, 2022, at 4:30 p.m. Eastern...

SCTL : 1.1000 (+0.92%)
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe

Agreement Highlights Momentum in Onshoring of Contract Manufacturing Projects to U.S. from Sites Around the World...

SCTL : 1.1000 (+0.92%)
Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products

Societal to Receive Greater Portion of Profit Sharing from Verapamil PM Product Sales Societal Awarded Potential New GMP Manufacturing Agreements for...

SCTL : 1.1000 (+0.92%)
Societal CDMO Reports Inducement Grants for New Staff

SAN DIEGO and GAINESVILLE, Ga., July 07, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and...

SCTL : 1.1000 (+0.92%)
Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish and Lyophilization Unit at San Diego Facility

Japanese Biopharmaceutical Company Engages Societal for Formulation, Fill/Finish and Lyophilization Activities to Support Ongoing Clinical Development of...

SCTL : 1.1000 (+0.92%)
Societal to Participate in Upcoming Investor Conferences

SAN DIEGO and GAINESVILLE, Ga., May 19, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development...

SCTL : 1.1000 (+0.92%)
Societal CDMO Reports First Quarter 2022 Financial Results

Recorded Q1 Revenue of $21 Million; A 26% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Early Stage Through...

SCTL : 1.1000 (+0.92%)
Societal CDMO Signs Three-Year Manufacturing and Supply Agreement With InfectoPharm for Ritalin LA® in Europe

Agreement Establishes Societal as Exclusive Supplier in Europe Through 2023...

SCTL : 1.1000 (+0.92%)

Business Summary

Societal CDMO is a bi-coastal contract development and manufacturing organization with capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. Societal CDMO,...

See More

Key Turning Points

3rd Resistance Point 1.1133
2nd Resistance Point 1.1067
1st Resistance Point 1.1033
Last Price 1.1000
1st Support Level 1.0933
2nd Support Level 1.0867
3rd Support Level 1.0833

See More

52-Week High 1.2800
Last Price 1.1000
Fibonacci 61.8% 0.8904
Fibonacci 50% 0.7700
Fibonacci 38.2% 0.6496
52-Week Low 0.2600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.